Btomorrow Ventures

Founded in 2019, Btomorrow Ventures is the corporate venture capital arm of British American Tobacco based in London, United Kingdom. The firm seeks to invest in health and wellness, functional products, science, sustainability, and technology sectors.

Joshua Galpin

Investment Manager

Lukasz Garbowski

Investment Director

George Leivadas

Investment Analyst

Luca Marras

Investment Analyst

Sam Morris

Investment Associate

Juan M. Palacios

Managing Director

Jamie Price

Sustainability Investment Associate

Lexy Prosszer

Investment Principal

Alexandra Prosszer

Principal

Lisa Smith

Managing Director

Kory Sun

Investment Associate

Kory S.

Analyst

Past deals in Cannabis

Open Book Extracts

Series C in 2022
Open Book Extracts is a cGMP certified company specializing in the cultivation, processing, and manufacturing of premium plant-based products derived from hemp. The company focuses on producing broad-spectrum cannabinoid products that aim to harness the therapeutic benefits of hemp for various applications. Open Book Extracts offers a range of services, including white labeling, private labeling, and contract manufacturing, allowing businesses to procure raw materials and develop customized products that align with their brand identity.

The Kanvas

Venture Round in 2022
Operator of vaporizers and consumer technology intended to enhance cannabis oil's marketability by developing purposeful blends of duration, flavor, and experience. The company offers a proprietary assortment of premium storage and vaporization technology and leverages trustworthy materials, premium design, and accredited laboratories for testing, also integrates the industry's only proprietary temperature-dosing technology, enabling adult and medical cannabis consumers to get access to a range of glass jars for cannabis flowers and also get full customization capabilities.

Cannopeia

Seed Round in 2022
Cannopeia is developing proprietary technology to ensure the safe and effective use of cannabis. They have devices such as the Smart Vaporizer and Formulation Device that enables medical and non-medical cannabis users to manage their cannabis consumption. This device effectively controls the dosage and mixing formulations on-demand. In addition, these devices integrate sensors and instruments designed to gather data about the effects and efficacy of physician-prescribed and over-the-counter cannabis treatments and to serve as a personal digital cannabis coach for medical and wellness users. Cannopeia was founded by Bernard Juster in 2019.

Trait Biosciences

Series A in 2021
Trait Biosciences Inc. is a biotechnology company focused on advancing the hemp and cannabis industry through innovative technologies. Established in 2017 and headquartered in Vancouver, Canada, with additional offices in Santa Fe and a laboratory in Los Alamos, New Mexico, the company offers a range of products and solutions. These include water-soluble cannabinoids, enhancements in cannabinoid production and crop yield, and non-chemical solutions for protecting crops against pathogens. Trait Biosciences also provides tailored solutions that allow growers to create specific cannabinoid profiles for consumer and clinical needs, as well as technologies to produce THC-free hemp. Through its research and development efforts, Trait Biosciences aims to transform cannabinoid cultivation and product development.

Cannopeia

Seed Round in 2021
Cannopeia is developing proprietary technology to ensure the safe and effective use of cannabis. They have devices such as the Smart Vaporizer and Formulation Device that enables medical and non-medical cannabis users to manage their cannabis consumption. This device effectively controls the dosage and mixing formulations on-demand. In addition, these devices integrate sensors and instruments designed to gather data about the effects and efficacy of physician-prescribed and over-the-counter cannabis treatments and to serve as a personal digital cannabis coach for medical and wellness users. Cannopeia was founded by Bernard Juster in 2019.

Trait Biosciences

Series A in 2021
Trait Biosciences Inc. is a biotechnology company focused on advancing the hemp and cannabis industry through innovative technologies. Established in 2017 and headquartered in Vancouver, Canada, with additional offices in Santa Fe and a laboratory in Los Alamos, New Mexico, the company offers a range of products and solutions. These include water-soluble cannabinoids, enhancements in cannabinoid production and crop yield, and non-chemical solutions for protecting crops against pathogens. Trait Biosciences also provides tailored solutions that allow growers to create specific cannabinoid profiles for consumer and clinical needs, as well as technologies to produce THC-free hemp. Through its research and development efforts, Trait Biosciences aims to transform cannabinoid cultivation and product development.

Cannopeia

Series A in 2020
Cannopeia is developing proprietary technology to ensure the safe and effective use of cannabis. They have devices such as the Smart Vaporizer and Formulation Device that enables medical and non-medical cannabis users to manage their cannabis consumption. This device effectively controls the dosage and mixing formulations on-demand. In addition, these devices integrate sensors and instruments designed to gather data about the effects and efficacy of physician-prescribed and over-the-counter cannabis treatments and to serve as a personal digital cannabis coach for medical and wellness users. Cannopeia was founded by Bernard Juster in 2019.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.